Cannabinoid-2 Agonism with AM2301 Mitigates Morphine-Induced Respiratory Depression
- 1 October 2021
- journal article
- research article
- Published by SAGE Publications in Cannabis & Cannabinoid Research
- Vol. 6 (5) , 401-412
Abstract
Introduction: An escalating number of fatalities resulting from accidental opioid overdoses typically attributed to respiratory depression continue to define the opioid epidemic. Opioid respiratory depression results from a decrease in reflexive inspiration within the preBötzinger complex in the brainstem. Objective: Cannabinoid receptor agonism is reported to enhance opioid analgesia, yet whether cannabinoids enhance or inhibit opioid-induced respiratory depression is unknown. Methods: Studies herein sought to define the roles of cannabinoid-1 receptor (CB1R) and cannabinoid-2 receptor (CB2R) on respiratory depression using selective agonists alone and in combination with morphine in male mice. Results: Using whole body plethysmography, the nonselective CB1R and CB2R agonist (Δ 9 -tetrahydrocannabinol) and the CB1R synthetic cannabinoid, AM356, induced respiratory depression, whereas the well-published selective CB2 agonist, JWH 133, and the novel CB2 agonist (AM2301) did not. Moreover, a selective CB2R agonist (AM2301) significantly attenuated morphine sulfate-induced respiratory depression. Conclusion: Notably, findings suggest that attenuation of opioid-induced respiratory depression relies on CB2R activation, supporting selective CB2R agonism as an opioid adjunct therapy.Keywords
This publication has 33 references indexed in Scilit:
- Disease modification of breast cancer–induced bone remodeling by cannabinoid 2 receptor agonistsJournal of Bone and Mineral Research, 2012
- Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to NeuroprotectionStroke, 2012
- In Vivo Characterization of MMP-2200, a Mixed δ/μ Opioid Agonist, in MiceThe Journal of Pharmacology and Experimental Therapeutics, 2011
- PreBötzinger Complex Neurokinin-1 Receptor-Expressing Neurons Mediate Opioid-Induced Respiratory DepressionThe Journal of Neuroscience, 2011
- Incidence, Reversal, and Prevention of Opioid-induced Respiratory DepressionAnesthesiology, 2010
- Central effects of the cannabinoid receptor agonist WIN55212‐2 on respiratory and cardiovascular regulation in anaesthetised ratsBritish Journal of Pharmacology, 2004
- Agonist‐inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630British Journal of Pharmacology, 1999
- Pharmacology of cannabinoid CB1 and CB2 receptorsPharmacology & Therapeutics, 1997
- Characterization of a rat model of incisional painPain, 1996
- Quantitative assessment of tactile allodynia in the rat pawJournal of Neuroscience Methods, 1994